Category: Amgen

Arrowhead Receives $25M Milestone Cost from Amgen

Publicly traded biopharmaceutical firm Arrowhead Prescription drugs introduced yesterday a $25 million milestone cost triggered by the primary topic enrolled in Amgen’s Section 3 trial...